Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

BACKGROUND: Research on the disease severity of COVID-19 in patients with rheumatic immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term prospective data on the development of SARS-CoV-2 antibodies in these patients are lacking. METHODS: Adult patients with rheumatic IM...

Descripción completa

Detalles Bibliográficos
Autores principales: Boekel, Laura, Hooijberg, Femke, Vogelzang, Erik H, Besten, Yaëlle R, Leeuw, Maureen, Atiqi, Sadaf, van Vollenhoven, Ronald F, Wijbrandts, Carla A, Gerritsen, Martijn, Krieckaert, C, Dijkshoorn, Bas, Bakhlakh, Siham, Crooijmans, Juliette J, Voskuyl, Alexandre, van der Horst-Bruinsma, Irene E, Lems, Willem, Kuijpers, Taco W, van Ham, S Marieke, Wieske, Luuk, Eftimov, Filip, Kummer, Laura Y, van Dam, PJ Koos, Stalman, Eileen W, Steenhuis, Maurice, Keijzer, Sofie, Cristianawati, Olvi, Keijser, Jim, Loeff, Floris C, Tas, Sander W, Nurmohamed, Michael T, Boers, Maarten, Rispens, Theo, Wolbink, Gertjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983412/
https://www.ncbi.nlm.nih.gov/pubmed/35383121
http://dx.doi.org/10.1136/rmdopen-2021-002035

Ejemplares similares

Ejemplares similares